- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02919397
Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes
Effectiveness of Integrating Motivational Instant Messaging Into an E-diabetes Prevention Programme in People at High Risk of Type 2 Diabetes: a Prospective, Parallel-group, Randomised Controlled Trial (Diabetes Stopwatch)
Visão geral do estudo
Status
Condições
Descrição detalhada
The study will examine whether a wearable technology, combined with biofeedback, motivational messaging and an e-diabetes prevention programme, is effective in reducing weight and increasing physical activity after 12 months.
The intervention will consist of a wearable technology and a smartphone application made available for a 12 month period. 22 online multimedia sessions targeting diet, physical activity and mental resilience delivered via the smartphone application. Motivational messaging based on the diabetes prevention module content and biofeedback will be sent to participants via the application.
The control group will receive the wearable technology and will have access to a smartphone application detailing their activity. Participants will be directed to the same educational material as is made available via the multimedia sessions, but will not receive motivational messages.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- HbA1c between 42 and 47 mmol/mol
- BMI≥25 kg/m²
- Fluent in conversational English
- Permanent resident in Lambeth, Southwark or Lewisham
- Ownership of a smartphone (iPhone or Android only) for communication defined as logging on at least once/day to the internet
- Ambulatory.
Exclusion Criteria:
- Known diabetes
- Pregnancy or planning pregnancy during the duration of the study
- Severe mental illness (severe depression, psychosis, bipolar affective disorder, dementia, learning difficulties, substance problem use or dependence)
- Severe physical disability e.g. that would prevent any increased uptake of physical exercise
- Advanced active disease such as cancer or heart failure
- Any other condition which requires glucose altering drugs
- Morbid obesity (BMI ≥50 kg/m²)
- Current participation in a weight loss programme.
When in doubt the investigators will seek the GP opinion and approval.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Intervention
If participants are allocated to the intervention group, participants will receive the wearable technology and access to the smartphone application.
Motivational messages based on diabetes prevention programme content, and biofeedback messages based on physical activity data provided via the wearable technology, will be received by participants via the application.
The diabetes prevention programme educational material will be available via the application.
|
Buddi wearable technology will record activity levels, participants will access activity data through smartphone application
Educational material accessed through smartphone application
Messages sent via smartphone application
|
Comparador Ativo: Control
If participants are allocated to the control group, participants will receive the wearable technology and will be able to access their activity data via the smartphone application.
Participants will also have have access to the diabetes prevention programme educational material via the application.
Participants will not receive motivational messages related to the education content or activity data.
|
Buddi wearable technology will record activity levels, participants will access activity data through smartphone application
Educational material accessed through smartphone application
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Physical activity (average steps per day)
Prazo: 7 days
|
Average steps taken per day from 7 days wear measured using the Buddi wearable technology, which will be worn 24 hours per day for 7 days
|
7 days
|
Weight (kg)
Prazo: At 12 month follow-up appointment
|
Measured in light clothing, without shoes, on the a Class 3 Tanita SC240 weighing digital scale to 0.01 kg for weight
|
At 12 month follow-up appointment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
HbA1c (mmol/mol)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Height (cm)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
BMI (kg/m^2)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Waist circumference (cm)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Hip circumference (cm)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Total cholesterol (mmol/L)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
High density lipoprotein cholesterol (mmol/L)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Low density lipoprotein cholesterol (mmol/L)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Systolic blood pressure (mmHg)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Diastolic blood pressure (mmHg)
Prazo: At 12 month follow-up appointment
|
At 12 month follow-up appointment
|
|
Sleep duration (average hours per night)
Prazo: 7 days
|
The Buddi wearable technology will be worn for 24 hours per day.
Therefore, during sleeping hours participant activity will be measured and duration of sleep can be calculated.
Participants will wear the Buddi device for 7 days, and the average number of hours sleep per night will be calculated.
|
7 days
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Khalida Ismail, King's College London
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 197384
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Wearable technology
-
Taichung Veterans General HospitalConcluído
-
University of LiegeConcluídoCefaleia em salvas crônicaBélgica
-
Abbott Medical DevicesConcluídoDoença da Valva Aórtica | Distúrbio da Valva AórticaEstados Unidos, Canadá, Portugal, Reino Unido, Estônia, Alemanha, Holanda, Bélgica, França, Itália, Polônia, Espanha
-
Yonsei UniversityConcluídoDor de pescoço | Câncer de tireoideRepublica da Coréia
-
University of PennsylvaniaUniversity of Wisconsin, Madison; Philips Healthcare; National Aeronautics and...Concluído
-
Douglas Mental Health University InstituteNational Alliance for Research on Schizophrenia and DepressionAtivo, não recrutandoDepressão, Bipolar | Transtorno Bipolar Tipo IICanadá
-
Fondazione Policlinico Universitario Agostino Gemelli...ConcluídoOsteoartrite, Joelho | Osteoartrite, Quadril | Equilíbrio; distorcido | Distúrbios da Marcha na VelhiceItália
-
Fondazione Policlinico Universitario Agostino Gemelli...ConcluídoDerrame | Distúrbios da Marcha Neurológicos | EquilíbrioItália
-
Medtronic Neurovascular Clinical AffairsMedtronic Bakken Research CenterConcluídoAneurisma IntracranianoReino Unido, Dinamarca, Israel, França, Espanha, Alemanha, Grécia, Austrália, Finlândia, Hungria, Itália
-
Universidad Europea de MadridConcluídoDor lombopélvica pós-parto